#-071 Methyl-1-testosterone
Product Profile: Methyl-1-testosterone
Chemical Name:
17beta-hydroxy-17alpha-methylandrost-4-en-3-one; Mesterone; Andrometh; 17-Methyl Testosterone; Nu-man; ;Metandren
Molecular Formula: C20H30O2
Molecular Weight: 302.45
Melting Point: 162-168 ° C
Assay: 99.5%
Appearance: White powder
Description :
17A-Methyl-1-Testosterone is an orally administered testosterone compound that carries the same nature as all compounds. Like all testosterone compounds, Methyltestosterone also carries a strong aromatizing nature; aromatization refers to the conversion of testosterone into estrogen. A highly versatile anabolic steroid, beyond its oral administration the one thing that distinguishes from its injectable counterparts is that Methyltestosterone is C17-alpha alkylated (C17-aa). This is a trait held by most oral anabolic steroids, but one most injectable steroids do not carry with a few exceptions. As is the case, like all C17-aa steroids carries a hepatotoxic nature, and in this case, it is one that is quite strong.
A fast acting testosterone compound, 17A-Methyl-1-Testosterone carries an active half-life of approximately seven hours, and on this basis must be administered on a daily basis.Of course, the good news is as a fast acting compound the testosterone benefits will be displayed rapidly; however, they will also be extremely short lived.
Application
17A-Methyl-1-Testosterone is useful for treatment of testosterone deficiency, breast cancer and menopause treatment. Some athletes also use the drug to improve workouts.
In males, 17A-Methyl-1-Testosterone can treat conditions such as testicular failure or delayed puberty caused by low levels of testosterone. The medication balances the testosterone levels in users, correcting a low level of the hormone.
17A-Methyl-1-Testosterone is commonly used as part of breast cancer treatment. The drug helps to slow the growth of the cancer by changing the hormonal makeup of cancer cells. This change prevents the cell division that is necessary for the cancer to spread.
Women also can use estrogen with 17A-Methyl-1-Testosterone in menopausal treatments. Prior to menopause, women produce large amounts of the hormone estrogen and smaller amounts of testosterone. With the onset of menopause, however, fewer of both hormones are produced. Hormone replacement therapy with estrogen and reduces the severity of symptoms such as hot flashes and sexual dysfunction.
Doses:
Most inexperienced users will begin using 17A-Methyl-1-Testosterone in doses of about 30-50mgs per day and adjust as needed. Due to the issues related to hepatoxicity it is recommended that users limit their use of this compound to only a few weeks. Limiting the usage of this drug to 4-6 weeks would help to avoid any serious complications that could become a problem in terms of liver toxicity.